Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2009

Tri-Lo-Sprintec(Norgestimate-Ethinyl Estradiol)Teva Pharmaceutical Industries Limited logoTEVA

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Teva Pharmaceutical Industries Limited

$4,981

Medicare cost, 2024

Medicare drug plans spent $4,981 on Tri-Lo-Sprintec (norgestimate-ethinyl estradiol) in 2024, for 213 prescriptions and refills filled by 134 patients. Spending fell 95% from 2023 to 2024. It is made by Teva Pharmaceutical Industries Limited (TEVA).

Medicare cost, 2024

$4,981

-95.4% from 2023

Prescriptions

213

$23.38 per claim

Patients

134

138 prescribers

Total spending, 2024

$4,981

$37.17 per patient

Questions and answers

How much does Medicare spend on Tri-Lo-Sprintec?

Medicare prescription drug plans paid $4,981 for Tri-Lo-Sprintec in 2024, for 213 prescriptions and refills to 134 patients (down 95.4% from 2023). The average cost per claim was $23.38.

Which state spends the most on Tri-Lo-Sprintec?

New York had the highest Medicare cost for Tri-Lo-Sprintec in 2024: $565 for 30 claims, followed by California ($538).

Who makes Tri-Lo-Sprintec?

Tri-Lo-Sprintec is made by Teva Pharmaceutical Industries Limited (TEVA), listed in the Medicare spending data as Teva USA.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Tri-Lo-Sprintec was $4,981 in 2024, after a high of $236K in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Prescriber data by year

YearPrescribersClaimsPatientsCost
20221,5935,7991,436$177K
20239983,609892$108K
2024138213134$4,981

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Teva USATEVA logoTEVA213$4,981

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
2
RxNorm concept IDs
578732, 748797, 749155, 749156, 749157
Application numbers
ANDA076784

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube